Track the 차백신연구소 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 차백신연구소 has published 30 reports. Market capitalisation: €73.6bn. The latest transaction was filed on 11 May 2026 (Sale). Among the most active insiders: 고정재. Every trade is accessible without an account.
30
Insider Decl.
0
Thresholds
€39m
4 ops.
Buy Volume
€23m
6 ops.
Sell Volume
22Σ signal
Buys €39m€23m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,120 of 26,293 companies
30.3
score / 100
Value
11
Quality
49
FCF yld-15%
Earn yld-22%
EV/EBITDA·
ROE-89%
Gross mgn91%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.